In leukemia, it was reported that RNF220 promotes the proliferation of leukemic cells and reduces the degradation of the CyclinD1 protein through USP22, which indicated that RNF220 might play an important role in the progression of AML (24). This evidence concerns the gene RNF220 and leukemia.